Nantahala Capital Management, LLC Tarsus Pharmaceuticals, Inc. Transaction History

Nantahala Capital Management, LLC

  • $1.5 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$19.61 - $39.22 $4.41 Million - $8.82 Million
-224,955 Reduced 59.94%
150,321 $5.46 Million
Q4 2023

Feb 14, 2024
BUY
$12.98 - $20.73 $3.11 Million - $4.97 Million
239,776 Added 176.96%
375,276 $7.6 Million
Q3 2023

Nov 14, 2023
BUY
$14.75 - $24.62 $2 Million - $3.34 Million
135,500 New
135,500 $2.41 Million

Others Institutions Holding TARS

# of Institutions
155
Shares Held
40.4M
Call Options Held
37.9K
Put Options Held
808K
View Full List

About Tarsus Pharmaceuticals, Inc.

TARS Quotes by TradingView
  • Ticker TARS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,658,500
  • Market Cap $815M
  • Description
  • Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...
More about TARS
Track This Portfolio

Track Nantahala Capital Management, LLC Portfolio

Follow Nantahala Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nantahala Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email